0 results for 'Allergan USA, Inc.'
Corporate Department of the Year, Global M&A: Latham & Watkins
Working at breakneck speed, it helped Allergan sell its generics business for $40 billion.Cite as 16 C.D.O.S. 4601 ASHLEY GLENNEN, Plaintiff and Appellant, v. ALLERGAN, INC., Def
The Am Law 100: Signs of a Slowdown
The Am Law 100 eked out gains across major financial metrics in 2015. But growth was the slowest in years.Cite as: In re: North Sea Crude Oil Futures Litigation, 1:13-cv-03473, NYLJ 1202754585157, at *1 (SDNY, Decided March 29, 2016) CASENAME In re: North Sea
Cite as: ICP Strategic Credit Income Fund, 13-12116, NYLJ 1202737441896, at *1 (SDNY, Decided September 15, 2015) CASE NAME ICP STRATEGIC CREDIT INCOME MASTER
Cite as: Sullivan v. Aventis, 14-cv-2939, NYLJ 1202735209608, at *1 (SDNY, Decided August 12, 2015) CASENAME Angela Rose Sullivan, Plaintiff v. Aventis,
What's in a Label? Proving Induced Infringement for 'Off-Label' Use
Dorothy Auth, Danielle Tully and Peng Lin of Cadwalader, Wickersham & Taft highlight recent law and provide guidance on the perils of instructions for use with respect to off-label use for drug innovators and generic drug manufacturers alike.